CYP2A6: a human coumarin 7-hydroxylase

By Pelkonen O.   Rautio A.   Raunio H.   Pasanen M.  

Toxicology, Vol. 144, Iss. 1, 2000-04 ,pp. : 139-147

Elsevier

Access to resources Recommend Favorite

Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity

By Lewis D.F.V.   Dickins M.   Lake B.G.   Eddershaw P.J.   Tarbit M.H.   Goldfarb P.S.  

Toxicology, Vol. 133, Iss. 1, 1999-03 ,pp. : 1-33

Elsevier

Access to resources Recommend Favorite

Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes

By Asikainen A.   Tarhanen J.   Poso A.   Pasanen M.   Alhava E.   Juvonen R.O.  

Toxicology in Vitro, Vol. 17, Iss. 4, 2003-08 ,pp. : 449-455

Elsevier

Access to resources Recommend Favorite

Carbaryl InducesCYP1A1Gene Expression in HepG2 and HaCaT Cells but Is Not a Ligand of the Human Hepatic Ah Receptor

By Ledirac N.   Delescluse C.   de Sousa G.   Pralavorio M.   Lesca P.   Amichot M.   Berge J.B.   Rahmani R.  

Toxicology and Applied Pharmacology, Vol. 144, Iss. 1, 1997-05 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite

Genetic polymorphism of CYP2A6 in the German population

By Bourian M.   Gullsten H.   Legrum W.  

Toxicology, Vol. 144, Iss. 1, 2000-04 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite